GoKawiil
Tech News
Researchers analyzed the DNA of Jonathan, a giant tortoise believed to be nearly two centuries old, to identify factors contributing to his remarkable lifespan. The study aims to uncover genetic markers that could inform human aging research.
Dr. Darshan Shah, a surgeon turned wellness entrepreneur, identified common frustrations with traditional healthcare settings and created Next Health, a clinic chain emphasizing comfort and advanced treatments. The company now operates over 25 locations worldwide, offering services from health testing to hormone therapy.
The Pentagon is developing a program called Polygraph+ (or Polygraph Next) that uses AI and machine learning to score truthfulness, alongside 'standoff sensing' techniques that gather physiological data without attaching devices to a subject. Separately, new research on transplanted hearts challenges the idea that young organs can rejuvenate older recipients, complicating theories popularized by comments from Vladimir Putin and Xi Jinping about biotechnology extending life.
Boston Longevity Week, an 11-day series of events including biomarker conferences, an AI hackathon and an investor pitch night with over 30 venture firms, culminates in a Translational Longevity Summit. The event's organizers argue the longevity field's core challenge isn't a lack of innovation or even regulation, but a failure to translate promising research into validated, clinically usable treatments.
Apple has released an early version of its redesigned Health app to developers testing iOS 27.2, ahead of a planned public rollout later in 2026. The update adds an Insights tab summarizing sleep, fitness and readiness trends, plus a Longevity tab featuring a 'Health Age' score and movement assessments for flexibility, strength and balance, with commentary from health experts tied to user data.
Apple released iOS 27.2 beta 1 to developers, skipping version 27.1, bringing the revamped Health app it teased at its September event. The update adds an Insights tab powered by Apple Intelligence and a Longevity tab featuring Health Age and AI-driven movement assessments for flexibility, strength and balance.
Apple's redesigned Health app appeared in the first iOS 27.2 developer beta, adding an Insights tab with Apple Intelligence-driven suggestions, a Longevity tab showing a Health Age and readiness score, at-home movement assessments, and eventually blood panel ordering through Quest Diagnostics. Apple says some features, including personalized summaries and recommendations, will roll out gradually across future betas ahead of a full public release in late 2026.
Apple has released the first developer beta of iOS 27.2 featuring its overhauled Health app, first unveiled at last week's event by VP of Health and Fitness Sumbul Desai. Key additions like an AI-powered Insights tab, a Longevity tab with Health Age scoring, readiness metrics, at-home movement assessments, and Quest Diagnostics blood panel ordering will roll out gradually across future betas rather than all at once. Apple says the full public release is expected in late 2026, with beta feedback shaping the final version.
After his daughter Lucy suffered a brain hemorrhage that left her blind, billionaire Bill Ackman used his connections to secure her advanced care at Mount Sinai and pursue an experimental treatment. In May, the FDA granted her medical team first-time emergency authorization to transplant mitochondria from her leg muscle into her eyes in an attempt to repair her optic nerves. Ackman has since pledged over $400 million to establish an institute focused on longevity and brain health research.
Dutch phone maker Fairphone has launched its Gen 6+ device in the US market, built around a 6.31-inch OLED screen and designed so users can replace parts themselves rather than send devices out for repair. CTO Chandler Hatton says the company set out to prove that modular, long-lasting smartphones are achievable despite skepticism from the industry.
A startup called Generation claims a combination of two generic drugs can reverse aging effects, citing informal reports from a small group of participants describing benefits like improved vision, better grip strength, and increased libido. The company plans a larger trial of 100+ people, but is already distributing the drug to others before any rigorous evidence confirms its effectiveness. The trial will be overseen by alternative-medicine practitioners, including a doctor previously linked to promoting FDA-discredited covid-19 treatments.